Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Time in range and HbA1C after 6 months with a multidisciplinary program for children and adolescents with diabetes mellitus, real world data from Mexico City.

Ramírez-Mendoza F, González JE, Gasca E, Camacho M, Cruz MV, Caraveo D, Velázquez A, Cruz Z, Segoviano M, Romano M, Diego M, Made AM, de León DC, Gay-Molina J, Prada D.

Pediatr Diabetes. 2020 Feb;21(1):61-68. doi: 10.1111/pedi.12921. Epub 2019 Oct 22.

2.

Comparison of Automated and Manual DNA Isolation Methods of Liquid-Based Cytology Samples.

Domínguez-Vigil IG, Barajas-Olmos VH, Gallardo-Alvarado L, Pérez-Maya AA, Garza-Rodríguez ML, Magallanes-Garza GI, Cardona-Huerta S, Méndez-Lozano DH, Vidal-Gutiérrez O, Cantú De León DF, Barrera-Saldaña HA.

Biopreserv Biobank. 2019 Dec;17(6):591-597. doi: 10.1089/bio.2018.0148. Epub 2019 Sep 26.

3.

A Multi-Center Study of BRCA1 and BRCA2 Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population.

Millan Catalan O, Campos-Parra AD, Vázquez-Romo R, Cantú de León D, Jacobo-Herrera N, Morales-González F, López-Camarillo C, Rodríguez-Dorantes M, López-Urrutia E, Pérez-Plasencia C.

Cancers (Basel). 2019 Aug 26;11(9). pii: E1246. doi: 10.3390/cancers11091246.

4.

The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer.

Salgado-Albarrán M, González-Barrios R, Guerra-Calderas L, Alcaraz N, Estefanía Sánchez-Correa T, Castro-Hernández C, Sánchez-Pérez Y, Aréchaga-Ocampo E, García-Carrancá A, Cantú de León D, Herrera LA, Baumbach J, Soto-Reyes E.

Oncogenesis. 2019 Aug 12;8(8):41. doi: 10.1038/s41389-019-0150-2.

5.

miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments.

Martinez-Gutierrez AD, Catalan OM, Vázquez-Romo R, Porras Reyes FI, Alvarado-Miranda A, Lara Medina F, Bargallo-Rocha JE, Orozco Moreno LT, Cantú De León D, Herrera LA, López-Camarillo C, Pérez-Plasencia C, Campos-Parra AD.

Int J Mol Med. 2019 Oct;44(4):1267-1280. doi: 10.3892/ijmm.2019.4292. Epub 2019 Jul 30.

6.

Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.

Hernández-Juárez J, Vargas-Sierra O, Herrera LA, Cantú De León D, Fernández-Retana J, Pérez-Plasencia C, López-Camarillo C, Gariglio P, Díaz-Chávez J.

Int J Oncol. 2019 May;54(5):1613-1624. doi: 10.3892/ijo.2019.4749. Epub 2019 Mar 14.

7.

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.

Gallardo-Alvarado LN, Tusié-Luna MT, Tussié-Luna MI, Díaz-Chávez J, Segura YX, Bargallo-Rocha E, Villarreal C, Herrera-Montalvo LA, Herrera-Medina EM, Cantu-de Leon DF.

BMC Cancer. 2019 Feb 1;19(1):118. doi: 10.1186/s12885-019-5312-2.

8.

Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study.

Lino-Silva LS, Gamboa-Domínguez A, Zúñiga-Tamayo D, Salcedo-Hernández RA, Cetina L, Cantú-de-León D.

World J Clin Oncol. 2018 Nov 10;9(7):133-139. doi: 10.5306/wjco.v9.i7.133.

9.

Prognostic factors associated with uterine sarcomas: the experience of a single institution.

Barquet-Muñoz SA, Isla-Ortiz D, Montalvo-Esquivel G, Cantú-de-León D, Salcedo-Hernández RA, Cordoba-Gonzalez V, Herrera-Gómez Á.

J Obstet Gynaecol. 2019 Feb;39(2):231-236. doi: 10.1080/01443615.2018.1492529. Epub 2018 Oct 24.

PMID:
30354797
10.

Advancing clinical research globally: Cervical cancer research network from Mexico.

Ager BJ, Gallardo-Rincón D, de León DC, Chávez-Blanco A, Chuang L, Dueñas-González A, Gómez-García E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Pérez-Plasencia C, Plante M, Poveda A, Gaffney DK.

Gynecol Oncol Rep. 2018 Jun 12;25:90-93. doi: 10.1016/j.gore.2018.06.007. eCollection 2018 Aug. Review.

11.

CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines.

Guerra-Calderas L, González-Barrios R, Patiño CC, Alcaraz N, Salgado-Albarrán M, de León DC, Hernández CC, Sánchez-Pérez Y, Maldonado-Martínez HA, De la Rosa-Velazquez IA, Vargas-Romero F, Herrera LA, García-Carrancá A, Soto-Reyes E.

Oncotarget. 2018 Mar 30;9(24):17028-17042. doi: 10.18632/oncotarget.24798. eCollection 2018 Mar 30.

12.

A prognostic score for survival in patients older than 65 years with Diffuse Large B-Cell Lymphoma.

Candelaria M, Reynoso-Noverón N, Ponce M, Castillo-Llanos R, Nolasco-Medina D, Cantú-De-Leon D.

Rev Invest Clin. 2018;70(1):46-52. doi: 10.24875/RIC.18002450.

13.

Lactate dehydrogenase as a prognostic marker in neoplastic meningitis.

Cacho-Díaz B, Lorenzana-Mendoza NA, Reyes-Soto G, Hernández-Estrada A, Monroy-Sosa A, Guraieb-Chahin P, Cantu-de-León D.

J Clin Neurosci. 2018 May;51:39-42. doi: 10.1016/j.jocn.2018.02.014. Epub 2018 Feb 23.

PMID:
29483012
14.

MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.

Pedroza-Torres A, Campos-Parra AD, Millan-Catalan O, Loissell-Baltazar YA, Zamudio-Meza H, Cantú de León D, Montalvo-Esquivel G, Isla-Ortiz D, Herrera LA, Ángeles-Zaragoza Ó, Robelo-Romero G, Herrera-Gómez Á, Pérez-Plasencia C.

Oncol Rep. 2018 Mar;39(3):1532-1540. doi: 10.3892/or.2018.6219. Epub 2018 Jan 18.

PMID:
29399698
15.

[Breast osteosarcoma originating in a phyllodes tumor. Report of one case].

Nieto-Coronel T, Salazar-Campos JE, León DC, Díaz-Molina R, Vázquez-Romo R, Bargalló-Rocha E.

Rev Med Chil. 2017 Aug;145(8):1076-1082. doi: 10.4067/s0034-98872017000801076. Spanish.

16.

Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.

Barquet-Muñoz SA, Cruz-Rodríguez E, Cantú De León DF, Isla-Ortiz D, Montalvo-Esquivel G, Herrera-Montalvo LA, Pérez-Plasencia C, Pérez-Montiel D, Herrera-Gómez Á.

Rev Invest Clin. 2017 Sep-Oct;69(5):286-292.

17.

Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients.

Fernandez-Retana J, Zamudio-Meza H, Rodriguez-Morales M, Pedroza-Torres A, Isla-Ortiz D, Herrera L, Jacobo-Herrera N, Peralta-Zaragoza O, López-Camarillo C, Morales-Gonzalez F, Cantu de Leon D, Pérez-Plasencia C.

Tumour Biol. 2017 Jun;39(6):1010428317711895. doi: 10.1177/1010428317711895.

PMID:
28639897
18.

Detection of Actinomyces spp. in cervical exudates from women with cervical intraepithelial neoplasia or cervical cancer.

García-García A, Coronel-Martínez J, Leon DC, Romero-Figueroa MDS, Caballero-Pantoja YE, Manzanares-Leal GL, Rodriguez-Morales M, Sandoval-Trujillo H, Ramírez-Durán N.

J Med Microbiol. 2017 Jun;66(6):706-712. doi: 10.1099/jmm.0.000485. Epub 2017 Jun 8.

PMID:
28590243
19.

Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.

Salgado-Ceballos I, Ríos J, Pérez-Montiel D, Gallardo L, Barquet-Muñoz S, Salcedo-Hernández R, Pérez-Plasencia C, Herrera LA, Cantú de León DF.

Int J Surg. 2017 May;41:1-5. doi: 10.1016/j.ijsu.2017.03.023. Epub 2017 Mar 14.

20.

Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer.

Barquet-Muñoz SA, Rendón-Pereira GJ, Acuña-González D, Peñate MV, Herrera-Montalvo LA, Gallardo-Alvarado LN, Cantú-de León DF, Pareja R.

World J Surg Oncol. 2017 Jan 14;15(1):23. doi: 10.1186/s12957-016-1067-2.

Supplemental Content

Loading ...
Support Center